MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,896,800 | -72.8% | 1,890,000 | -59.9% | 0.65% | -65.5% |
| Q2 2023 | $21,641,850 | -11.2% | 4,715,000 | -4.3% | 1.89% | -5.8% |
| Q1 2023 | $24,378,750 | -53.0% | 4,925,000 | -48.2% | 2.01% | -50.1% |
| Q4 2022 | $51,897,300 | -25.6% | 9,505,000 | -11.5% | 4.02% | -12.3% |
| Q3 2022 | $69,783,000 | +5.6% | 10,735,786 | -23.2% | 4.58% | -18.0% |
| Q2 2022 | $66,084,000 | -32.3% | 13,971,334 | 0.0% | 5.59% | +27.6% |
| Q1 2022 | $97,660,000 | -31.4% | 13,971,334 | 0.0% | 4.38% | +9.1% |
| Q4 2021 | $142,368,000 | -16.5% | 13,971,334 | 0.0% | 4.01% | -5.5% |
| Q3 2021 | $170,590,000 | – | 13,971,334 | – | 4.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |